Zydus Lifesciences informs about press release

10 Nov 2023 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated November 10, 2023 titled ‘Zydus and Torrent sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

894.95 -12.65 (-1.39%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×